Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed2

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT03792256Phase 1Completed
Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)
Acute LeukemiaLeukemia, LymphocyticLymphoblastic Lymphoma+3 more
StudychairStart date: 2019-04-11
NCT00098839Phase 1/2Completed
Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)
Recurrent Childhood Acute Lymphoblastic Leukemia
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Acute LeukemiaPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score9%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Acute LeukemiaPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

K A Bradstock), Dr.

Westmead Hospital

Related
1 trials

Shared therapeutic areas:

Acute Leukemia
Similarity Score4%

J Szer, Dr.

Royal Melbourne Hospital, Parkville, Australia

Related
1 trials

Shared therapeutic areas:

Acute Leukemia
Similarity Score4%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score4%

E Gluckman, Dr.

Hopital St Louis, Paris, France

Related
1 trials

Shared therapeutic areas:

Acute Leukemia
Similarity Score4%

J Rowe, Dr.

Rambam Medical Center, Haifa, Israel

Related
1 trials

Shared therapeutic areas:

Acute Leukemia
Similarity Score4%

G Lambertenghi-Deliliers, Dr.

Padiglione G Marcora, Ospedale Maggiore di Milano, Italy

Related
1 trials

Shared therapeutic areas:

Acute Leukemia
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03792256Phase 1StudyChair

Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)

Acute LeukemiaLeukemia, LymphocyticLymphoblastic Lymphoma+3 more
Completed
NCT00098839Phase 1/2PrincipalInvestigator

Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)

Recurrent Childhood Acute Lymphoblastic Leukemia
Completed

All 2 trials loaded